The news: CVS reported better-than-expected Q4 revenues while providing guidance for 2025 that pleased Wall Street. Shares of the company surged ~15% on the heels of Wednesday’s earnings report.
The topline numbers:
- Q4 revenues hit $97.7 billion, up 4.2% year over year.
- Full-year revenues increased to $372.8 billion, also up 4.2% YoY.
- Full-year profits were $4.6 billion, but down about 45% from $8.4 billion the year prior.
- Each of CVS’ business segments (health insurance, pharmacy and consumer wellness, and health services) beat expectations in Q4.